Global Blood Therapeutics, Inc.: What is the Best Funding Choice?
- Published in:
- Journal of Critical Incidents, 2017, v. 10, p. 47
- By:
- Publication type:
- Article
Works matching DE "GLOBAL Blood Therapeutics Inc."
Results: 5
1
2
To Consign or Not to Consign?
- Published in:
- Journal of Critical Incidents, 2017, v. 10, p. 44
- By:
- Publication type:
- Article
3
Safety of L-tryptophan produced by fermentation using Escherichia coli CGMCC 3667, for all animal species based on a dossier submitted by GBT Europe GmbH.
- Published in:
- EFSA Journal, 2016, v. 14, n. 1, p. n/a, doi. 10.2903/j.efsa.2016.4343
- Publication type:
- Article
4
Safety of L-threonine produced by fermentation using Escherichia coli CGMCC 3703, for all animal species based on a dossier submitted by GBT Europe GmbH.
- Published in:
- EFSA Journal, 2016, v. 14, n. 1, p. n/a, doi. 10.2903/j.efsa.2016.4344
- Publication type:
- Article
5
Innovative startups 2012.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 3, p. 194, doi. 10.1038/nbt.2518
- By:
- Publication type:
- Article